Viewing Study NCT01393756


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2025-12-25 @ 9:10 PM
Study NCT ID: NCT01393756
Status: COMPLETED
Last Update Posted: 2023-12-05
First Post: 2011-07-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma
Sponsor: The Lymphoma Academic Research Organisation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module